Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BY-NC-SA 4.0Neurobiology of Disease

Loss of Snord115 mitigates Snord116-driven sleep abnormalities in mouse models of Prader-Willi syndrome

Abstract

Prader-Willi syndrome (PWS) is a neurodevelopmental disorder caused by the loss of paternally expressed genes within the imprinted 15q11-q13 locus, which includes clusters of box C/D small nucleolar RNAs (SNORDs), notably the SNORD115 and SNORD116 gene families. Although SNORD116 deletions have been associated with sleep disturbances in patients and mouse models, the respective contributions of SNORD115 and SNORD116 to sleep regulation remain unclear. Here, we combined polysomnographic recordings and quantitative neuroanatomy to assess sleep-wake architecture, sleep homeostasis, and hypothalamic alterations in mice carrying paternal deletions of Snord115, Snord116, or both clusters. Snord116 deletion selectively increased REM sleep, particularly during the light phase and after sleep deprivation, without affecting slow-wave sleep or REM-associated theta activity. In contrast, Snord115 deletion alone did not alter sleep. Unexpectedly, combined Snord115/Snord116 deletion abolished the REM sleep phenotype observed in Snord116-deficient mice, indicating that Snord115 loss attenuates Snord116-dependent REM sleep alterations. Melanin-concentrating hormone (MCH) neuron density was reduced in Snord116-KO and double-KO mice, whereas hypocretin neurons were preserved across genotypes. However, REM sleep alterations did not parallel MCH neuron loss. Transcriptomic analyses revealed only limited hypothalamic gene expression changes. Together, these findings uncover an unexpected interaction between Snord115 and Snord116 in REM sleep regulation and highlight the complexity of modeling sleep dysfunctions associated with PWS.

Related

  1. The DGKK mRNA is a primary target of the Prader-Willi syndrome-associated snoRNA SNORD116
    S. Louis, O. Cakil, A. Thevenin +10
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
  2. Box C/D SNORD116-17 promotes prostate cancer progression by targeting the miR-206/E2F5 axis
    Xiuyi Pan, Yifan Kang, Jinjing Zhong +9
    iSciencePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationOncologyCell PressCrossrefEurope PMC
  3. NONO mitigates transcription-replication conflicts during replication stress by restraining BRD4-dependent transcription elongation
    Wenchi Wu, Chengyan Ding, Jiameng Ma +14
    Cell ReportsPeer-reviewedCC BY-NC 4.0Molecular biology & gene regulationCrossref
  4. Copy number variants in fetuses with non-structural ultrasound abnormalities among pregnant women without adverse pregnancy history
    Jianwen Lian, Liubing Lan, Wenjuan Luo +7
    Frontiers in geneticsPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  5. Deep learning mitigates batch effects in Raman spectroscopy
    Joel Sjöberg, Adrian Lita, Mioara Larion +1
    Scientific ReportsPeer-reviewedCC BY 4.0Full textBiophysicsCrossrefPMC
BibTeX
@article{riviere2026loss,
  title = {{Loss of Snord115 mitigates Snord116-driven sleep abnormalities in mouse models of Prader-Willi syndrome}},
  author = {Julie C Rivière and Virginie Marty and Jérôme Cavaillé and Laure Verret},
  journal = {Neurobiology of Disease},
  year = {2026},
  month = oct,
  doi = {10.1016/j.nbd.2026.107551},
  url = {https://hal.science/hal-05781221v1},
  note = {CC BY-NC-SA 4.0},
}
RIS
TY  - JOUR
TI  - Loss of Snord115 mitigates Snord116-driven sleep abnormalities in mouse models of Prader-Willi syndrome
AU  - Julie C Rivière
AU  - Virginie Marty
AU  - Jérôme Cavaillé
AU  - Laure Verret
PY  - 2026
DA  - 2026/10/06
JO  - Neurobiology of Disease
DO  - 10.1016/j.nbd.2026.107551
UR  - https://hal.science/hal-05781221v1
AB  - Prader-Willi syndrome (PWS) is a neurodevelopmental disorder caused by the loss of paternally expressed genes within the imprinted 15q11-q13 locus, which includes clusters of box C/D small nucleolar RNAs (SNORDs), notably the SNORD115 and SNORD116 gene families. Although SNORD116 deletions have been associated with sleep disturbances in patients and mouse models, the respective contributions of SNORD115 and SNORD116 to sleep regulation remain unclear. Here, we combined polysomnographic recordings and quantitative neuroanatomy to assess sleep-wake architecture, sleep homeostasis, and hypothalamic alterations in mice carrying paternal deletions of Snord115, Snord116, or both clusters. Snord116 deletion selectively increased REM sleep, particularly during the light phase and after sleep deprivation, without affecting slow-wave sleep or REM-associated theta activity. In contrast, Snord115 deletion alone did not alter sleep. Unexpectedly, combined Snord115/Snord116 deletion abolished the REM sleep phenotype observed in Snord116-deficient mice, indicating that Snord115 loss attenuates Snord116-dependent REM sleep alterations. Melanin-concentrating hormone (MCH) neuron density was reduced in Snord116-KO and double-KO mice, whereas hypocretin neurons were preserved across genotypes. However, REM sleep alterations did not parallel MCH neuron loss. Transcriptomic analyses revealed only limited hypothalamic gene expression changes. Together, these findings uncover an unexpected interaction between Snord115 and Snord116 in REM sleep regulation and highlight the complexity of modeling sleep dysfunctions associated with PWS.
SN  - 0969-9961
SN  - 1095-953X
ER  -